Change in Cognitive Functioning Following Acute Antidepressant Treatment in Late-Life Depression

American Journal of Geriatric Psychiatry

Volumn 17, Issue 10, 2009, Pages 881-888

  Culang, Michelle E ^a,b   Sneed, Joel R ^a,b   Keilp, John G ^b   Rutherford, Bret R ^b   Pelton, Gregory H ^b   Devanand, D P ^b   Roose, Steven P ^b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Citalopram; Cognitive functioning; Cognitive impairment; Geriatric depression; Late life depression

Indexed keywords

CITALOPRAM; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

AGED; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL HOSPITAL; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; OUTPATIENT; PSYCHOMOTOR ACTIVITY; TREATMENT RESPONSE; WECHSLER INTELLIGENCE SCALE;

EID: 70349683028     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e3181b4bf4a     Document Type: Article

References (40)

1. Salloway S, Malloy P, Kohn R, et al: MRI and neuropsychological differences in early- and late-life-onset geriatric depression. Neurology 1996; 46:1567-1574
2. Kramer-Ginsberg E, Greenwald BS, Krishnan KRR, et al: Neuropsychological functioning and mri signal hyperintensities in geriatric depression. Am J Psychiatry 1999; 156:438-444
3. Gallassi R, Di Sarro R, Morreale A, et al: Memory impairment in patients with late-onset major depression: the effect of antidepressant therapy. J Affect Disord 2006; 91:243-250
4. Butters MA, Whyte EM, Nebes RD, et al: The nature and determinants of neuropsychological functioning in late-life depression. Arch Gen Psychiatry 2004; 61:587-595
5. Lesser I, Boone K, Mehringer C, et al: Cognition and white matter hyperintensities in older depressed patients. Am J Psychiatry 1996; 153:1280-1287
6. Nebes RD, Butters MA, Mulsant BH, et al: Decreased working memory and processing speed mediate cognitive impairment in geriatric depression Psychol Med 2000; 30:679-691
7. Lockwood KA, Alexopoulos GS, van Gorp WG: Executive dysfunction in geriatric depression.[see comment]. Am J Psychiatry 2002; 159:1119-1126
8. Georgotas A, McCue RE, Reisberg B, et al: The effects of mood changes and antidepressants on the cognitive capacity of elderly depressed patients. Int Psychogeriatr 1989; 1:135-143
9. Nebes RD, Pollock BG, Mulsant BH, et al: Cognitive effects of paroxetine in older depressed patients. J Clin Psychiatry 1999; 60:26-29
10. Bondareff W, Alpert M, Friedhoff AJ, et al: Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life. Am J Psychiatry 2000; 157:729-736
11. Doraiswamy PM, Krishnan KR, Oxman T, et al: Does antidepressant therapy improve cognition in elderly depressed patients? J Gerontol A Biol Sci Med Sci 2003; 58:M1137-M1144
12. Portella MJ, Marcos T, Rami L, et al: Residual cognitive impairment in late-life depression after a 12-month period follow-up. Int J Geriatric Psychiatry 2003; 18:571-576
13. Butters MA, Becker JT, Nebes RD, et al: Changes in cognitive functioning following treatment of late-life depression. Am J Psychiatry 2000; 157:1949-1954
14. Nebes RD, Pollock BG, Houck PR, et al: Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. J Psychiatr Res 2003; 37:99-108
15. Raskin J, Wiltse CG, Siegal A, et al: Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial. Am J Psychiatry 2007; 164:900-909 (Pubitemid 46972905)
16. Roose SP, Sackeim HA, Krishnan KRR, et al: Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. Am J Psychiatry 2004; 161: 2050-2059
17. Sneed JR, Roose SP, Keilp JG, et al: Response inhibition predicts poor antidepressant treatment response in very old depressed patients. Am J Geriatr Psychiatry 2007; 15:553-563
18. Sneed JR, Keilp JG, Brickman AM, et al: The specificity of neuropsychological impairment in predicting antidepressant non-response in the very old depressed. Int J Geriatr Psychiatry 2008; 23:319-323
19. Cohen JD, MacWhinney B, Flatt M, et al: PsyScope: an interactive graphic system for designing and controlling experiments in the psychology laboratory using Macintosh computers. Behav Res Methods Instruments Comput 1993; 25:257-271
20. Folstein MF, Folstein SE, McHugh PR: Mini-mental state: a practical method for grading the state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
21. Wechsler D: Wechsler Adult Intelligence Scale 3rd Revision (WAIS-III). San Antonio, Psychological Corporation, 1997
22. Thorne DR, Genser SG, Sing HC, et al: The Walter reed performance assessment battery. Neurobehav Toxicol Teratol 1998; 7:415-418
23. MacLeod C: A half-century of research on the Stroop effect: an integrative review. Psychol Bull 1991; 109:163-203
24. Benton AL, Sivan AB, Hamsher K, et al: Contributions to Neuropsychological Assessment. New York, Oxford, 1983
25. Buschke H, Fuld P: Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 1974; 24:1019-1025
26. Schafer JL, Olsen MK: Multiple imputation for multivariate missing- data problems: a data analyst's perspective. Multivariate Behav Res 1998; 33:545-571
27. Schafer JL: Multiple imputation: a primer. Stat Methods Med Res 1999; 8:3-15
28. Schafer JL, Graham JW: Missing data: our view of the state of the art. Psychol Methods 2002; 7:147-177
29. Cohen J, Cohen P, West SG, et al: Applied Multiple Regression/ Correlation for the Behavioral Sciences. 3rd ed. Mahwah, NJ, Lawrence Erlbaum Associates Publishers, 2003
30. Taylor WD, MacFall JR, Steffens DC, et al: Localization of age-associated white matter hyperintensities in late-life depression. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 539-544
31. Murray AD, Staff RT, Shenkin SD, et al: Brain white matter hyperintensities: relative importance of vascular risk factors in nondemented elderly people. Radiology 2005; 237:251-257
32. Krishnan KR, Hays JC, Blazer DG: MRI-defined vascular depression. Am J Psychiatry 1997; 154:497-501
33. Chew ML, Mulsant BH, Pollock BG, et al: Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc 2008; 56:1333-1341
34. Schmitt JAJ, Kruizinga MJ, Riedel WJ: Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors. J Psychopharmacol 2001; 15:173-179
35. Furlan PM, Kallan MJ, Ten Have T, et al: Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteers. Geriatr Psychiatry 2001; 9:429-438
36. Zobel AW, Schulze-Rauschenbach S, von Widdern OC, et al: Improvement of working but not declarative memory is correlated with HPA normalization during antidepressant treatment. J Psychiatr Res 2004; 38:377-383
37. Harmer CJ, Bhagwagar Z, Cowen PJ, et al: Acute administration of citalopram facilitates memory consolidation in healthy volunteers. Psychopharmacology 2002; 163:106-110
38. Baldwin D, Johnson FN: Tolerability and safety of citalopram. Rev Contemp Pharmacother 1995; 6:315-325
39. Ravaglia G, Forti P, Lucicesare A, et al: Prevalent depressive symptoms as a risk factor for conversion to mild cognitive impairment in an elderly Italian cohort. Am J Geriatr Psychiatry 2008; 16:834-843
40. Devanand DP, Pelton GH, Marston K, et al: Sertraline treatment of elderly patients with depression and cognitive impairment. Int J Geriatr Psychiatry 2003; 18:123-130